How to Evaluate and Try Biotechgate Before Committing

Biotechgate offers two low-commitment entry points: a free trial and a demo request. Start with the free trial if you want to test the AI-guided search and research workflows against your own BD&L questions; request a demo if you need a guided walkthrough first, since the site presents "See the platform in action" as a short video walkthrough of the AI-guided search workflows. Either way, the goal of an evaluation is to confirm that Biotechgate's coverage and workflows match your target therapeutic areas, regions, and existing processes before you commit budget.

What you can actually try

Biotechgate is positioned as an AI-guided life sciences intelligence platform with two workflows:

• BD&L Intelligence — search in plain language across companies, assets, licensing opportunities, deals, trials, financing rounds, management contacts, and partnering interests. The platform translates a natural-language query into structured results, so no complex query language is required.
• AI Research Workspace — ask questions across curated analyst reports and financial models to support due diligence, valuation, pipeline assessment, and market research, with sourced insights from trusted research content.

Both are built on the same underlying data layer, so a trial should test whether that layer answers the questions your team actually asks.

Coverage to check against your needs

Use these figures as the benchmark for your evaluation — if your target area or region is thin here, the workflows won't compensate:

A practical trial checklist

Run these tests during the free trial rather than browsing features:

1. Natural-language search test. Enter a query the way you'd phrase it to a colleague — e.g., a specific indication plus development phase plus region — and check whether the structured output matches what you'd expect from manual research.
2. Coverage spot-check. Pick three companies or assets you already know well and verify their profiles, pipeline stages, and licensing status are accurate and current.
3. Contact quality. Pull management contacts for a target company and assess whether they're the right functional roles for outreach.
4. Research workspace test. Ask a due-diligence-style question across the analyst reports and check that answers come with sources you can trace.
5. Workflow fit. Compare the output format against how your team currently documents BD&L decisions — if it doesn't slot into your process, note the gap.

Choosing between trial and demo

• Free trial — best if you have a specific question to answer and want to judge data quality and search relevance firsthand.
• Demo request — best if you need to see the AI-guided workflows explained before investing time, or if you're evaluating on behalf of a team and need a shared reference point.

The site does not publish pricing or plan details, so treat the trial and demo as the way to establish fit first; commercial terms come after.

What to decide at the end

By the close of your evaluation you should be able to answer: does the coverage match my therapeutic areas and regions, do the two AI workflows replace enough manual research to justify the switch, and does the output support the specific decisions my team makes — licensing, partnering, investment, or due diligence. If the answer to all three is yes, move to a commercial conversation; if coverage is thin in your niche, that's the deciding factor regardless of how well the workflows perform.